# Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

> **NCT02483182** · PHASE2 · COMPLETED · sponsor: **Shulov Innovate for Science Ltd. 2012** · enrollment: 210 (actual)

## Conditions studied

- Herpes Labialis

## Interventions

- **DRUG:** ZEP-3 ointment 1.0%
- **DRUG:** Acyclovir cream 5%

## Key facts

- **NCT ID:** NCT02483182
- **Lead sponsor:** Shulov Innovate for Science Ltd. 2012
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-06-24
- **Final completion:** 2018-06-24
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483182, "Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02483182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*